ABSTRACT
Endophytic bacteria improve the growth, physiology, and metabolite profile of plants. They are known as potential biocontrol agents of soil-borne diseases. This study evaluated the effects of endophytic bacterial strains on growth, vase life, biochemical attributes, and antioxidant and nematicidal activities of French marigold (Tagetes patula). French marigold seeds were sole and consortium inoculated with three promising endophytic bacterial strains, Burkholderia phytofirmans (PsJN), Enterobacter sp. (MN17), and Bacillus sp. (MN54). The vase life of French marigold was promoted by 66.6% in the individual application of PsJN and 100% in plants treated with consortium compared to the uninoculated control. The shoot and root fresh weights were also increased by 65.9 and 68.7%, with the combined application of all three strains. The total phenolics, flavonoid, and protein contents were higher in consortium treatment with an increase of up to 38.0, 55.9, and 65.9%, respectively, compared to the uninoculated control. Furthermore, combined application of endophytic bacterial strains promoted DPPH radical scavenging, mortality of plant-parasitic nematodes, and ferric reducing antioxidant power activities with increase of up to 278.0, 103.8, and 178.0%, respectively, compared to uninoculated control. An increase in antioxidant activities of ascorbate peroxidase (APX), catalase (CAT), glutathione peroxidase (GPX), and superoxide dismutase (SOD) were observed up to 77.3, 86.0, 91.6, and 102.9%, respectively by combined application of endophytic bacterial strains. So, given the economic importance of floriculture crops, endophytic bacterial isolates studied here have shown a great potential for improving the productivity of cultivated ornamental French marigold.
ABSTRACT
Methods to determine individualized breast cancer risk lack sufficient sensitivity to select women most likely to benefit from preventive strategies. Alterations in DNA methylation occur early in breast cancer. We hypothesized that cancer-specific methylation markers could enhance breast cancer risk assessment. We evaluated 380 women without a history of breast cancer. We determined their menopausal status or menstrual cycle phase, risk of developing breast cancer (Gail model), and breast density and obtained random fine-needle aspiration (rFNA) samples for assessment of cytopathology and cumulative methylation index (CMI). Eight methylated gene markers were identified through whole-genome methylation analysis and included novel and previously established breast cancer detection genes. We performed correlative and multivariate linear regression analyses to evaluate DNA methylation of a gene panel as a function of clinical factors associated with breast cancer risk. CMI and individual gene methylation were independent of age, menopausal status or menstrual phase, lifetime Gail risk score, and breast density. CMI and individual gene methylation for the eight genes increased significantly (P < 0.001) with increasing cytological atypia. The findings were verified with multivariate analyses correcting for age, log (Gail), log (percent density), rFNA cell number, and body mass index. Our results demonstrate a significant association between cytological atypia and high CMI, which does not vary with menstrual phase or menopause and is independent of Gail risk and mammographic density. Thus, CMI is an excellent candidate breast cancer risk biomarker, warranting larger prospective studies to establish its utility for cancer risk assessment. Cancer Prev Res; 9(8); 673-82. ©2016 AACR.
